First look: testing new antibiotic in kids
NCT ID NCT07371429
Summary
This early study aims to understand how children's bodies process a single dose of a new antibiotic called gepotidacin. It involves 20 hospitalized children aged 2-12 who are already receiving standard antibiotic treatment for confirmed or suspected infections. Researchers will measure drug levels in the blood and monitor safety to gather initial information about how this medication works in children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.